Trademark: 87866981
Word

Status
Registered
Status Code
700
Status Date
Tuesday, September 24, 2019
Serial Number
87866981
Registration Number
5869213
Registration Date
Tuesday, September 24, 2019
Mark Type
2000
Filing Date
Friday, April 6, 2018
Published for Opposition
Tuesday, September 18, 2018

Trademark Owner History
Eagle Pharmaceuticals, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of cancer
Color is not claimed as a feature of the mark.
The mark consists of two darkly shaded asymmetrical pentagon shapes overlapping two identical lighter shaded asymmetrical pentagon shapes, with a darker area where the shapes overlap, the left asymmetrical pentagons are in the foreground and the right asymmetrical pentagons are in the background creating an illusion of distance.

Trademark Events
Sep 24, 2019
Registered-Principal Register
Aug 23, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Aug 22, 2019
Allowed Principal Register - Sou Accepted
Aug 21, 2019
Statement Of Use Processing Complete
Jul 25, 2019
Use Amendment Filed
Aug 21, 2019
Case Assigned To Intent To Use Paralegal
Jul 25, 2019
Teas Statement Of Use Received
Mar 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2019
Extension 1 Granted
Mar 4, 2019
Extension 1 Filed
Mar 4, 2019
Teas Extension Received
Nov 13, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 18, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 18, 2018
Published For Opposition
Aug 29, 2018
Notification Of Notice Of Publication E-Mailed
Aug 10, 2018
Assigned To Lie
Jul 30, 2018
Approved For Pub - Principal Register
Jul 30, 2018
Examiner's Amendment Entered
Jul 30, 2018
Notification Of Examiners Amendment E-Mailed
Jul 30, 2018
Examiners Amendment E-Mailed
Jul 30, 2018
Examiners Amendment -Written
Jul 24, 2018
Assigned To Examiner
Apr 17, 2018
Notice Of Design Search Code E-Mailed
Apr 16, 2018
New Application Office Supplied Data Entered In Tram
Apr 10, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24